MCM 2021 COVID-19 Coverage: Critical Care Pharmacotherapy: Reflection on the COVID-19 Pandemic Part 2: Antivirals and Immunomodulators

In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There are no comments yet.

Please log in to write the first comment.